Corporate News 12-Sep-22
Ajanta Pharma's Dahej unit undergoes USFDA audit
Receives two observations under form 483
Ajanta Pharma announced that the company's formulation facility at Dahej was inspected by US FDA from 5 September 2022 to 9 September 2022. At the end of the inspection, Form 483 was issued to the company with 2 procedural observations.
Previous News
Ajanta Pharma consolidated net profit rises 56.14% in the December 2023 quarter
( Results - Announcements 31-Jan-24 18:04 )
Ajanta Pharma fixes record date for buyback of shares
( Market Beat - Reports 28-Dec-21 14:39 )
Ajanta Pharma fixes record date for 2nd interim dividend
( Market Beat - Reports 31-Jan-24 17:37 )
Ajanta Pharma consolidated net profit declines 20.71% in the June 2017 quarter
( Results - Announcements 09-Aug-17 17:18 )
Ajanta Pharma to conduct board meeting
( Corporate News - 22-Jan-22 12:21 )
Volumes jump at Ajanta Pharma Ltd counter
( Hot Pursuit - 02-Mar-23 14:30 )
Board of Ajanta Pharma recommends Second Interim Dividend
( Corporate News - 31-Jan-24 17:15 )
Ajanta Pharma to conduct AGM
( Corporate News - 21-Jun-22 15:41 )
Ajanta Pharma to announce Quarterly Result
( Corporate News - 27-Apr-23 14:34 )
Board of Ajanta Pharma approves buy-back of shares
( Corporate News - 28-Dec-21 14:34 )
Ajanta Pharma to hold board meeting
( Corporate News - 20-Oct-17 10:40 )
Other Stories
Vardhan Capital & Finance schedules AGM
06-Jul-24 17:34
Automotive Axles schedules AGM
06-Jul-24 17:34
Maruti Infrastructure to conduct AGM
06-Jul-24 17:34
Torrent Power schedules AGM
06-Jul-24 17:34
Raghav Productivity Enhancers to hold AGM
06-Jul-24 17:34
Berger Paints India schedules AGM
06-Jul-24 17:33
Walpar Nutritions to conduct AGM
06-Jul-24 17:33
Weizmann AGM scheduled
06-Jul-24 17:33
Gretex Industries schedules AGM
06-Jul-24 17:33
Karma Energy schedules AGM
06-Jul-24 17:33
Back
Top
